Aristides Capital LLC Trims Stock Position in Amdocs Limited $DOX

Aristides Capital LLC trimmed its stake in Amdocs Limited (NASDAQ:DOX) by 30.6% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 2,210 shares of the technology company’s stock after selling 974 shares during the period. Aristides Capital LLC’s holdings in Amdocs were worth $202,000 as of its most recent SEC filing.

Other large investors have also recently modified their holdings of the company. Quarry LP raised its stake in Amdocs by 42.2% in the first quarter. Quarry LP now owns 391 shares of the technology company’s stock worth $36,000 after buying an additional 116 shares in the last quarter. Rossby Financial LCC purchased a new position in shares of Amdocs during the 2nd quarter worth approximately $41,000. SVB Wealth LLC bought a new position in shares of Amdocs in the 1st quarter worth approximately $43,000. Caitong International Asset Management Co. Ltd lifted its stake in shares of Amdocs by 537.8% in the 2nd quarter. Caitong International Asset Management Co. Ltd now owns 472 shares of the technology company’s stock valued at $43,000 after purchasing an additional 398 shares during the period. Finally, Neo Ivy Capital Management bought a new stake in shares of Amdocs during the second quarter valued at approximately $54,000. Institutional investors own 92.02% of the company’s stock.

Amdocs Stock Performance

Shares of DOX stock opened at $76.05 on Friday. The company has a market capitalization of $8.59 billion, a price-to-earnings ratio of 15.43, a price-to-earnings-growth ratio of 1.40 and a beta of 0.51. The company has a debt-to-equity ratio of 0.23, a quick ratio of 1.22 and a current ratio of 1.22. Amdocs Limited has a one year low of $74.32 and a one year high of $95.41. The company’s 50-day moving average is $81.40 and its 200 day moving average is $86.39.

Amdocs (NASDAQ:DOX) last issued its earnings results on Tuesday, November 11th. The technology company reported $1.83 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.82 by $0.01. The firm had revenue of $1.15 billion for the quarter, compared to the consensus estimate of $1.15 billion. Amdocs had a net margin of 11.94% and a return on equity of 19.66%. The business’s revenue was down 9.0% on a year-over-year basis. During the same quarter in the prior year, the firm posted $1.70 earnings per share. Amdocs has set its FY 2026 guidance at 7.270-7.550 EPS. Q1 2026 guidance at 1.730-1.790 EPS. Sell-side analysts expect that Amdocs Limited will post 6.21 EPS for the current fiscal year.

Amdocs Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, January 30th. Stockholders of record on Wednesday, December 31st will be paid a $0.527 dividend. The ex-dividend date is Wednesday, December 31st. This represents a $2.11 annualized dividend and a dividend yield of 2.8%. Amdocs’s payout ratio is currently 41.58%.

Analysts Set New Price Targets

A number of research firms have issued reports on DOX. Weiss Ratings reiterated a “hold (c)” rating on shares of Amdocs in a report on Thursday, October 30th. Bank of America decreased their price target on shares of Amdocs from $100.00 to $97.00 and set a “buy” rating for the company in a research note on Wednesday, November 12th. Wolfe Research reissued a “peer perform” rating on shares of Amdocs in a research note on Thursday, November 13th. Stifel Nicolaus cut their price objective on shares of Amdocs from $100.00 to $97.00 and set a “buy” rating on the stock in a report on Wednesday, November 12th. Finally, Wall Street Zen lowered shares of Amdocs from a “buy” rating to a “hold” rating in a report on Saturday, November 8th. Two investment analysts have rated the stock with a Buy rating and two have issued a Hold rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $97.00.

Amdocs Company Profile

Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.